Frøssing, Signe

Effect of liraglutide on ectopic fat in polycystic ovary syndrome: Arandomized clinical trial

Frøssing, S., Nylander, M., Chabanova, E., Frystyk, J., Holst, J. J., Kistorp, C., Skouby, S. O., & Faber, J. (2018) · Diabetes, Obesity and Metabolism

Ovarian function and disordersLiver Disease Diagnosis and Treatment

Cited by 178

Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial

Nylander, M., Frøssing, S., Clausen, H. V., Kistorp, C., Faber, J., & Skouby, S. O. (2017) · Reproductive BioMedicine Online

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 139

Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential

Nylander, M., Frøssing, S., Kistorp, C., Faber, J., & Skouby, S. O. (2017) · Endocrine Connections

Ovarian function and disordersVenous Thromboembolism Diagnosis and Management

Cited by 44

Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS

Frøssing, S., Nylander, M., Kistorp, C., Skouby, S. O., & Faber, J. (2018) · Endocrine Connections

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 38

Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study

Frøssing, S., Nylander, M., Aziz, M., Skouby, S. O., Kistorp, C., & Faber, J. (2017) · Gynecological Endocrinology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3